Tilray Brands (TLRY) has a profit margin of -152.83%, below the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Feb 2026
Trailing 12 months ending Feb 2026
The latest profit margin for TLRY is -152.83% as of February 2026. That compares with -113.85% in the prior-year period — down 34.2% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Tilray Brands's historical trend and sector peers before judging valuation or financial health.
Over the past year, TLRY's profit margin moved from -113.85% to -152.83% — a 34.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Tilray Brands's valuation or profitability profile.
Against Healthcare companies, TLRY currently prints -152.83% for profit margin, while the sector average sits near 15.58%. That is roughly 1080.7% below the sector mean. Large gaps often invite a closer look at Tilray Brands's growth, margins, and balance sheet.
Profit Margin shows how effectively Tilray Brands converts resources into returns. At -152.83%, TLRY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -113.85% in the prior-year period — down 34.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting TLRY's profit margin (-152.83%), review year-over-year change from -113.85%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.